Author:
Tsai Max,Lu Ze,Wang Jie,Yeh Teng-Kuang,Wientjes M. Guillaume,Au Jessie L.-S.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference40 articles.
1. M. Markman, E. Rowinsky, T. Hakes, B. Reichman, W. Jones, J. L. Lewis, Jr., S. Rubin, J. Curtin, R. Barakat, M. Phillips, and Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study. J. Clin. Oncol. 10(9):1485–1491 (1992).
2. J. L. Speyer, J. M. Collins, R. L. Dedrick, M. F. Brennan, A. R. Buckpitt, H. Londer, V. T. DeVita, Jr., and C. E. Myers. Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally. Cancer Res. 40(3):567–572 (1980).
3. S. Zimm, S. M. Cleary, W. E. Lucas, R. J. Weiss, M. Markman, P. A. Andrews, M. A. Schiefer, S. Kim, C. Horton, and S. B. Howell. Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide. Cancer Res. 47(6):1712–1716 (1987).
4. D. S. Alberts, P. Y. Liu, E. V. Hannigan, R. O’Toole, S. D. Williams, J. A. Young, E. W. Franklin, D. L. Clarke-Pearson, V. K. Malviya, and B. DuBeshter. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N. Engl. J. Med. 335(26):1950–1955 (1996).
5. D. K. Armstrong, B. Bundy, L. Wenzel, H. Q. Huang, R. Baergen, S. Lele, L. J. Copeland, J. L. Walker, and R. A. Burger. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N. Engl. J. Med. 354(1):34–43 (2006).
Cited by
112 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献